AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
LendingTree
TREE
$447M
| $932K | ﹤0.01% |
9,200
| – | – |
|
2277
Pembina Pipeline
PBA
$28.4B
| $931K | ﹤0.01% |
29,729
-9,984
| -25% | -$302K |
|
2278
Petrobras
PBR
$125B
| $928K | ﹤0.01% |
91,839
-43,922
| -32% | -$469K |
|
2279
Coherus Oncology
CHRS
$217M
| $927K | ﹤0.01% |
32,920
| – | – |
|
2280
Materion
MTRN
$4.39B
| $926K | ﹤0.01% |
23,381
| – | – |
|
2281
Ares Capital
ARCC
$13.5B
| $925K | ﹤0.01% |
56,080
+11,510
| +26% | +$181K |
|
|
SJR
2282
DELISTED
Shaw Communications Inc.
SJR
| $925K | ﹤0.01% |
46,114
-9,807
| -18% | -$195K |
|
2283
Colony Bankcorp
CBAN
$465M
| $921K | ﹤0.01% |
69,787
-61,372
| -47% | -$669K |
|
2284
Hyster-Yale Materials Handling
HY
$599M
| $921K | ﹤0.01% |
14,436
| – | – |
|
2285
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $921K | ﹤0.01% |
+11,451
| New | +$892K |
|
|
LHCG
2286
DELISTED
LHC Group LLC
LHCG
| $920K | ﹤0.01% |
20,124
| – | – |
|
|
DPLO
2287
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $920K | ﹤0.01% |
73,030
-1,910,073
| -96% | -$35.6M |
|
2288
First Bancorp
FBP
$4.42B
| $912K | ﹤0.01% |
137,900
| – | – |
|
|
FMSA
2289
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $912K | ﹤0.01% |
77,320
-2,500
| -3% | -$23.1K |
|
2290
TTEC Holdings
TTEC
$121M
| $911K | ﹤0.01% |
29,875
-2,500
| -8% | -$71.9K |
|
2291
Travere Therapeutics
TVTX
$5.2B
| $911K | ﹤0.01% |
48,102
+82
| +0.2% | +$1.68K |
|
|
EEP
2292
DELISTED
Enbridge Energy Partners
EEP
| $910K | ﹤0.01% |
35,700
-3,397
| -9% | -$82.8K |
|
2293
ArcBest
ARCB
$3.23B
| $908K | ﹤0.01% |
32,840
+1,700
| +5% | +$43.7K |
|
2294
Anika Therapeutics
ANIK
$258M
| $906K | ﹤0.01% |
18,500
| – | – |
|
|
QUOT
2295
DELISTED
Quotient Technology Inc
QUOT
| $905K | ﹤0.01% |
84,150
+2,100
| +3% | +$24.4K |
|
|
ANAT
2296
DELISTED
American National Group, Inc. Common Stock
ANAT
| $904K | ﹤0.01% |
7,254
+400
| +6% | +$48.9K |
|
2297
Caesarstone
CSTE
$72.3M
| $900K | ﹤0.01% |
31,400
-500
| -2% | -$15.9K |
|
2298
Sanofi
SNY
$103B
| $900K | ﹤0.01% |
22,264
+1,949
| +10% | +$76.8K |
|
2299
Alamo Group
ALG
$1.94B
| $898K | ﹤0.01% |
11,800
| – | – |
|
|
SRDX
2300
DELISTED
Surmodics
SRDX
| $897K | ﹤0.01% |
35,321
| – | – |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.